The role of active stimulation in patients that have benefited from the long-term effects of MCS in the treatment of orofacial pai
Withdrawn
- Conditions
- Trigeminal neuropathyFacial pain10019231
- Registration Number
- NL-OMON45382
- Lead Sponsor
- Radboud Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 12
Inclusion Criteria
For this study, we aim to include 12 patients that have undergone MCS for treating chronic orofacial pain. All patients have responded favourable to MCS (at least 40% pain reduction) and had at baseline a NRS > 5 (0= no pain, 10= worst possible pain). All patients underwent insertion of electrodes for MCS for chronic neuropathic pain between 2005 and 2012.
Exclusion Criteria
Patients who underwent the insertion of the MCS system after 2012 were excluded. Also, patients that showed an inadequate response to MCS (<40% pain relief) were excluded.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Pain scores, pain dimensions, Quality of Life, daily intake of pain medication<br /><br>with use of the McGill Pain Questionnaire (Dutch Version) and qualitative<br /><br>exploration of their experiences with use of interviews. </p><br>
- Secondary Outcome Measures
Name Time Method <p>-</p><br>